Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Completed

Conditions studied: Patients Transplanted With NiCord/CordIn (Omidubicel)

In brief

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Key facts

Study ID

NCT02039557

Run by

Gamida Cell ltd

People needed

33

Starts

2014-05-01

Expected to finish

2023-06-29

Last updated by the study team

2024-10-23

Who can join

Age: 2 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.

You may not qualify if…

• None

Where it is running

• UCSF Benioff Children's Hospital — Oakland, California, United States
• Loyola University, Cardinal Bernardin Cancer Center — Maywood, Illinois, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Vanderbilt — Nashville, Tennessee, United States
• University Medical Center Utrecht — Utrecht, Netherlands
• National University Cancer Institute — Singapore, Singapore
• Singapore General Hospital — Singapore, Singapore
• University Hospital Vall D'Hebron — Barcelona, Spain
• Hospital Universitario La Fe — Valencia, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.